Medullarythyroidcancer involves specific types of cells that are found in the thyroid gland and can occur spontaneously, or be part of a genetic syndrome.
Nothing is likely to answer the question definitely short of approving the drug, letting millions use it, and waiting to see whether more people get medullarythyroidcancer.